QID 20345

QID 20345: Oracle E-Business Suite Security Update (CPUAPR2023)

Oracle E-Business Suite is one of Oracle Corp.'s major product lines. Also known as Oracle EBS, it is an integrated set of business applications for automating customer relationship management (CRM), enterprise resource planning (ERP) and supply chain management (SCM) processes within organizations.

Affected Products:
Oracle E-Business Suite versions 12.2.3 - 12.2.12

NOTE:
we are using apps.ad_adop_session_patches and apps.fnd_product_groups tables to check version and patches so the scan user should have grant access for these tables.

QID Detection Logic(Auth):
Authentication via Oracle Database:
This QID reviews the Oracle output from the tables name apps.ad_adop_session_patches and apps.fnd_product_groups for version and patch information.

Successful attacks of this vulnerability can result in unauthorized read access to a subset of Oracle iReceivables, Oracle User Management accessible data and update, insert or delete access to some of Oracle iProcurement accessible data as well as unauthorized read access to a subset of Oracle iProcurement accessible data.

CVSS V3 rated as Medium - 5.4 severity.

CVSS V2 rated as Medium - 5.5 severity.

Solution

Refer to vendor advisory Oracle E-Business Suite April 2023.

Vendor References

ORACLE E-Business Suite cpuapr2023 - www.oracle.com/security-alerts/cpuapr2023.html

CVEs related to QID 20345

CVE-2023-21959 | CVE-2023-21997 | CVE-2023-21973 |

Software Advisories

Advisory ID	Software	Component	Link
ORACLE E-Business Suite cpuapr2023			www.oracle.com/security-alerts/cpuapr2023.html

By selecting these links, you may be leaving CVEreport webspace. We have provided these links to other websites because they may have information that would be of interest to you. No inferences should be drawn on account of other sites being referenced, or not, from this page. There may be other websites that are more appropriate for your purpose. CVEreport does not necessarily endorse the views expressed, or concur with the facts presented on these sites. Further, CVEreport does not endorse any commercial products that may be mentioned on these sites. Please address comments about any linked pages to [email protected].